chr10:45869624:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr10:45,869,624-45,941,567 |
| hg38 | chr10:45,374,176-45,446,119 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.002 | Cardiovascular Diseases | NA | BeFree | Detail | |
| 0.003 | Carotid Artery Diseases | NA | BeFree,GAD | Detail | |
| 0.080 | brain ischemia | NA | RGD | Detail | |
| 0.002 | Cerebrovascular Disorders | NA | GAD | Detail | |
| <0.001 | Bronchitis, Chronic | NA | BeFree | Detail | |
| 0.120 | colitis | NA | CTD_human | Detail | |
| 0.126 | Colonic Neoplasms | NA | BeFree,CTD_human,LHGDN | Detail | |
| 0.123 | Colonic Polyps | NA | BeFree,CTD_human,GAD | Detail | |
| <0.001 | colorectal carcinoma | NA | BeFree | Detail | |
| 0.003 | Colorectal Neoplasms | NA | BeFree,LHGDN | Detail | |
| 0.001 | Coronary Arteriosclerosis | NA | BeFree | Detail | |
| 0.002 | Coronary heart disease | NA | BeFree | Detail | |
| 0.120 | Drug Eruptions | NA | CTD_human | Detail | |
| <0.001 | dermatomyositis | NA | BeFree | Detail | |
| 0.003 | diabetes mellitus | NA | BeFree,GAD | Detail | |
| 0.003 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree,GAD | Detail | |
| <0.001 | Experimental Autoimmune Encephalomyelitis | NA | BeFree | Detail | |
| <0.001 | Enterocolitis | NA | BeFree | Detail | |
| 0.003 | Esophageal Neoplasms | NA | LHGDN | Detail | |
| 0.006 | glioblastoma | NA | BeFree,GAD,LHGDN | Detail | |
| 0.002 | Glioma | NA | GAD | Detail | |
| <0.001 | glomerulonephritis | NA | BeFree | Detail | |
| <0.001 | hepatitis B | NA | BeFree | Detail | |
| <0.001 | Hodgkin Disease | NA | BeFree | Detail | |
| <0.001 | Huntington disease | NA | BeFree | Detail | |
| 0.120 | Hyperalgesia | NA | CTD_human | Detail | |
| <0.001 | Hypercholesterolemia, Familial | NA | BeFree | Detail | |
| <0.001 | Hyperlipidemia | NA | BeFree | Detail | |
| 0.002 | Immediate hypersensitivity | NA | GAD | Detail | |
| 0.081 | Hypertensive disease | NA | BeFree,RGD | Detail | |
| 0.080 | Hypertension, Portal | NA | RGD | Detail | |
| 0.200 | pulmonary hypertension | NA | CTD_human,RGD | Detail | |
| 0.080 | Inflammation | NA | RGD | Detail | |
| 0.003 | Inflammatory Bowel Diseases | NA | BeFree,LHGDN | Detail | |
| <0.001 | ischemia | NA | BeFree | Detail | |
| 0.002 | Kidney Diseases | NA | GAD | Detail | |
| 0.003 | Kidney Failure, Chronic | NA | BeFree,GAD | Detail | |
| 0.003 | Kidney Neoplasm | NA | LHGDN | Detail | |
| <0.001 | leukemia | NA | BeFree | Detail | |
| <0.001 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
| 0.121 | Myeloid Leukemia, Chronic | Low leukotriene B4 receptor 1 leads to ALOX5 downregulation at diagnosis of chro... | BeFree,CTD_human | 25193960 | Detail |
| <0.001 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | NA | BeFree | Detail | |
| <0.001 | acute promyelocytic leukemia | NA | BeFree | Detail | |
| <0.001 | liver cirrhosis | NA | BeFree | Detail | |
| <0.001 | Liver neoplasms | NA | BeFree | Detail | |
| 0.002 | Chronic Obstructive Airway Disease | NA | GAD | Detail | |
| <0.001 | lymphoma | NA | BeFree | Detail | |
| <0.001 | multiple myeloma | NA | BeFree | Detail | |
| 0.120 | Multiple Organ Failure | NA | CTD_human | Detail | |
| 0.008 | myocardial infarction | NA | BeFree,GAD | Detail | |
| 0.080 | Myocardial Reperfusion Injury | NA | RGD | Detail | |
| 0.003 | myositis | NA | LHGDN | Detail | |
| 0.002 | narcolepsy | NA | GAD | Detail | |
| 0.120 | Neoplasm Invasiveness | NA | CTD_human | Detail | |
| 0.003 | Ischemic Cerebrovascular Accident | To investigate whether single nucleotide polymorphisms (SNPs) of eicosanoid bios... | BeFree | 21816595 | Detail |
| 0.003 | Ischemic stroke | To investigate whether single nucleotide polymorphisms (SNPs) of eicosanoid bios... | BeFree | 21816595 | Detail |
| 0.121 | Neoplasm Metastasis | NA | BeFree,CTD_human | Detail | |
| 0.080 | nephrotic syndrome | NA | BeFree,RGD | Detail | |
| <0.001 | obesity | NA | BeFree | Detail | |
| <0.001 | Degenerative polyarthritis | Our results showed that increased basal COL10A1 expression in OA hMSCs was signi... | BeFree | 25091567 | Detail |
| <0.001 | osteosarcoma | NA | BeFree | Detail | |
| <0.001 | ovarian carcinoma | NA | BeFree | Detail | |
| 0.080 | Pain | NA | RGD | Detail | |
| 0.003 | Pancreatic Neoplasm | NA | BeFree,LHGDN | Detail | |
| <0.001 | Periodontitis, Juvenile | NA | BeFree | Detail | |
| <0.001 | Pleural effusion disorder | NA | BeFree | Detail | |
| 0.080 | pleurisy | NA | RGD | Detail | |
| <0.001 | pneumonia | NA | BeFree | Detail | |
| <0.001 | polyps | NA | BeFree | Detail | |
| 0.005 | Prostatic Neoplasms | NA | LHGDN | Detail | |
| 0.080 | pulmonary edema | NA | RGD | Detail | |
| <0.001 | kidney failure | NA | BeFree | Detail | |
| 0.200 | Reperfusion Injury | NA | CTD_human,RGD | Detail | |
| 0.002 | Respiratory Syncytial Virus Infections | NA | GAD | Detail | |
| <0.001 | Retinal Diseases | NA | BeFree | Detail | |
| 0.002 | rhinitis | NA | GAD | Detail | |
| <0.001 | systemic scleroderma | NA | BeFree | Detail | |
| <0.001 | Septicemia | NA | BeFree | Detail | |
| 0.002 | sinusitis | NA | GAD | Detail | |
| 0.120 | Stomach Neoplasms | NA | CTD_human | Detail | |
| 0.010 | Cerebrovascular accident | Previous studies have implicated that two at-risk haplotypes (HapA and HapB) of ... | BeFree,GAD | 24198186 | Detail |
| 0.002 | Subarachnoid Hemorrhage | NA | GAD | Detail | |
| 0.003 | Testicular Neoplasms | NA | LHGDN | Detail | |
| 0.003 | tuberculosis | NA | BeFree,LHGDN | Detail | |
| <0.001 | Tuberculosis, Meningeal | NA | BeFree | Detail | |
| 0.003 | Tuberculosis, Pulmonary | NA | BeFree,GAD | Detail | |
| 0.123 | urticaria | NA | BeFree,CTD_human,LHGDN | Detail | |
| 0.002 | Vascular Diseases | NA | GAD | Detail | |
| 0.002 | Bronchial Hyperreactivity | NA | GAD | Detail | |
| <0.001 | polymyositis | NA | BeFree | Detail | |
| 0.002 | Intracranial Hemorrhages | NA | GAD | Detail | |
| <0.001 | Idiopathic pulmonary hypertension | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of mouth | NA | BeFree | Detail | |
| <0.001 | Aortic Aneurysm, Abdominal | 5-Lipoxygenase pathway in experimental abdominal aortic aneurysms. | BeFree | 25324573 | Detail |
| <0.001 | Tumor Progression | NA | BeFree | Detail | |
| <0.001 | Lung Diseases, Interstitial | NA | BeFree | Detail | |
| 0.080 | Radiation Pneumonitis | NA | RGD | Detail | |
| 0.003 | Adenomatous Polyps | NA | BeFree,LHGDN | Detail | |
| <0.001 | Lip and oral cavity carcinoma | NA | BeFree | Detail | |
| <0.001 | Adult type dermatomyositis | NA | BeFree | Detail | |
| <0.001 | Memory impairment | Absence of ALOX5 gene prevents stress-induced memory deficits, synaptic dysfunct... | BeFree | 25122659 | Detail |
| 0.001 | pancreatic carcinoma | Inhibition of 5-lipoxygenase triggers apoptosis in pancreatic cancer cells. | BeFree | 25483364 | Detail |
| <0.001 | Papillary thyroid carcinoma | NA | BeFree | Detail | |
| <0.001 | Fibrosis, Liver | The 5-lipoxygenase (5-LOX) pathway has been associated with a variety of inflamm... | BeFree | 25483364 | Detail |
| 0.002 | Malignant neoplasm of lung | NA | GAD | Detail | |
| 0.080 | Hyperoxia | NA | RGD | Detail | |
| <0.001 | Sepsis | NA | BeFree | Detail | |
| <0.001 | Childhood asthma | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of pancreas | In the present study, 5-LOX was found to be overexpressed not only in pancreatic... | BeFree | 25483364 | Detail |
| <0.001 | Xanthoma | NA | BeFree | Detail | |
| <0.001 | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | NA | BeFree | Detail | |
| <0.001 | Aortic aneurysm without mention of rupture NOS | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of pancreas | Inhibition of 5-lipoxygenase triggers apoptosis in pancreatic cancer cells. | BeFree | 25483364 | Detail |
| 0.004 | Malignant neoplasm of prostate | Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling ... | BeFree,GAD | 25540201 | Detail |
| 0.120 | Endotoxemia | NA | CTD_human | Detail | |
| <0.001 | Non-alcoholic Fatty Liver Disease | NA | BeFree | Detail | |
| <0.001 | Sleep Apnea, Obstructive | NA | BeFree | Detail | |
| <0.001 | Neurodegenerative Disorders | NA | BeFree | Detail | |
| <0.001 | Carotid Atherosclerosis | NA | BeFree | Detail | |
| <0.001 | Osteosarcoma of bone | NA | BeFree | Detail | |
| 0.002 | Carcinogenesis | NA | BeFree | Detail | |
| 0.002 | prostate carcinoma | Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling ... | BeFree | 25540201 | Detail |
| 0.002 | prostate carcinoma | Wedelolactone, a plant coumestan, was shown to act as anti-cancer agent for brea... | BeFree | 25934092 | Detail |
| <0.001 | Epithelial ovarian cancer | NA | BeFree | Detail | |
| 0.001 | breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of gastrointestinal tract | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of lymph node | These results suggest that the level of 5-LOX expression was increased in pancre... | BeFree | 25483364 | Detail |
| 0.001 | colon carcinoma | NA | BeFree | Detail | |
| 0.120 | Infarction, Middle Cerebral Artery | NA | CTD_human | Detail | |
| <0.001 | Idiopathic Inflammatory Myopathies | NA | BeFree | Detail | |
| 0.002 | Multiple Sclerosis, Relapsing-Remitting | NA | GAD | Detail | |
| <0.001 | Adenomatous polyp of colon | NA | BeFree | Detail | |
| 0.003 | ovarian neoplasm | NA | LHGDN | Detail | |
| 0.003 | Ischemic stroke | NA | BeFree | Detail | |
| 0.003 | Acute coronary syndrome | NA | BeFree,GAD | Detail | |
| <0.001 | Polyp of large intestine | NA | BeFree | Detail | |
| <0.001 | Tauopathies | Absence of ALOX5 gene prevents stress-induced memory deficits, synaptic dysfunct... | BeFree | 25122659 | Detail |
| <0.001 | Malignant neoplasm of ovary | NA | BeFree | Detail | |
| 0.002 | Blood pressure finding | NA | GAD | Detail | |
| 0.002 | Systemic arterial pressure | NA | GAD | Detail | |
| <0.001 | Inflammatory disorder | The 5-lipoxygenase (5-LOX) pathway has been associated with a variety of inflamm... | BeFree | 25483364 | Detail |
| <0.001 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
| <0.001 | Adenoma of large intestine | NA | BeFree | Detail | |
| 0.003 | Asthma, Aspirin-Induced | NA | BeFree,GAD | Detail | |
| 0.003 | Mammary Neoplasms | NA | BeFree,LHGDN | Detail | |
| <0.001 | Cancer Cell Growth | NA | BeFree | Detail | |
| <0.001 | Xenograft Model | NA | BeFree | Detail | |
| 0.008 | colorectal cancer | NA | BeFree,GAD | Detail | |
| <0.001 | Renal Insufficiency | NA | BeFree | Detail | |
| <0.001 | Glioblastoma multiforme | NA | BeFree | Detail | |
| <0.001 | Cirrhosis | NA | BeFree | Detail | |
| <0.001 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
| 0.120 | ASTHMA, DIMINISHED RESPONSE TO ANTILEUKOTRIENE TREATMENT IN | NA | CLINVAR | Detail | |
| <0.001 | Glucocorticoid Receptor Deficiency | NA | BeFree | Detail | |
| <0.001 | Aural atresia, congenital | NA | BeFree | Detail | |
| 0.120 | Atherosclerosis, susceptibility to | NA | CLINVAR | Detail | |
| 0.004 | coronary artery disease | NA | BeFree,GAD | Detail | |
| <0.001 | Moderate persistent asthma | NA | BeFree | Detail | |
| 0.001 | liver carcinoma | NA | BeFree | Detail | |
| <0.001 | Chronic kidney disease stage 5 | NA | BeFree | Detail | |
| 0.080 | Acute kidney injury | NA | RGD | Detail | |
| <0.001 | Promyelocytic leukemia | NA | BeFree | Detail | |
| 0.002 | Cerebral Hemorrhage | NA | GAD | Detail | |
| <0.001 | Idiopathic pulmonary arterial hypertension | NA | BeFree | Detail | |
| 0.003 | Ischemic Cerebrovascular Accident | NA | BeFree | Detail | |
| <0.001 | aortic valve disease 2 | NA | BeFree | Detail | |
| 0.003 | Infection | NA | LHGDN | Detail | |
| 0.002 | Hyperhomocystinemia | NA | GAD | Detail | |
| 0.003 | adenocarcinoma | NA | LHGDN | Detail | |
| 0.121 | adenoma | NA | BeFree,CTD_human | Detail | |
| 0.010 | Alzheimer's disease | Absence of ALOX5 gene prevents stress-induced memory deficits, synaptic dysfunct... | BeFree,GAD,LHGDN | 25122659 | Detail |
| <0.001 | amyloidosis | NA | BeFree | Detail | |
| <0.001 | amyotrophic lateral sclerosis | NA | BeFree | Detail | |
| 0.001 | Aneurysm | Inhibition of 5-LO by pharmacological or genetic approaches attenuates aneurysm ... | BeFree | 25324573 | Detail |
| 0.001 | aortic aneurysm | Targeted interruption of the 5-LO pathway is a potential treatment strategy in A... | BeFree | 25324573 | Detail |
| <0.001 | aortic valve stenosis | NA | BeFree | Detail | |
| 0.005 | arteriosclerosis | The eicosanoid genes ALOX5, ALOX5AP and LTA4H have been implicated in atheroscle... | BeFree | 25721704 | Detail |
| <0.001 | arthritis | Our results provide the evidence that the administration of 5-LOX inhibitors is ... | BeFree | 25229347 | Detail |
| 0.121 | rheumatoid arthritis | The lipoxygenase isoform of 5-lipoxygenase (5-LOX) is reported to be overexpress... | BeFree,CTD_human | 25229347 | Detail |
| 0.171 | asthma | The 5-lipoxygenase (5-LOX) pathway has been associated with a variety of inflamm... | BeFree,CTD_human,GAD,LHGDN | 25483364 | Detail |
| 0.171 | asthma | The 5-lipoxygenase product 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) is ... | BeFree,CTD_human,GAD,LHGDN | 26032638 | Detail |
| <0.001 | Asthma, Exercise-Induced | NA | BeFree | Detail | |
| <0.001 | Astrocytoma | NA | BeFree | Detail | |
| 0.139 | atherosclerosis | The eicosanoid genes ALOX5, ALOX5AP and LTA4H have been implicated in atheroscle... | BeFree,CTD_human,GAD,LHGDN | 25721704 | Detail |
| 0.002 | Malignant neoplasm of urinary bladder | NA | GAD | Detail | |
| 0.003 | Bladder Neoplasm | NA | LHGDN | Detail | |
| <0.001 | Blast Phase | On treatment initiation, ALOX5 levels increased in all patients except those who... | BeFree | 25193960 | Detail |
| <0.001 | Brain Neoplasms | NA | BeFree | Detail | |
| 0.001 | Malignant neoplasm of breast | NA | BeFree | Detail | |
| 0.002 | Bronchiolitis, Viral | NA | GAD | Detail | |
| 0.001 | Malignant tumor of colon | NA | BeFree | Detail | |
| <0.001 | Rectal Carcinoma | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Low leukotriene B4 receptor 1 leads to ALOX5 downregulation at diagnosis of chronic myeloid leukemia... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| To investigate whether single nucleotide polymorphisms (SNPs) of eicosanoid biosynthesis genes are a... | DisGeNET | Detail |
| To investigate whether single nucleotide polymorphisms (SNPs) of eicosanoid biosynthesis genes are a... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Our results showed that increased basal COL10A1 expression in OA hMSCs was significantly suppressed ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Previous studies have implicated that two at-risk haplotypes (HapA and HapB) of gene-encoding 5-lipo... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| 5-Lipoxygenase pathway in experimental abdominal aortic aneurysms. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Absence of ALOX5 gene prevents stress-induced memory deficits, synaptic dysfunction and tauopathy in... | DisGeNET | Detail |
| Inhibition of 5-lipoxygenase triggers apoptosis in pancreatic cancer cells. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The 5-lipoxygenase (5-LOX) pathway has been associated with a variety of inflammatory diseases inclu... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In the present study, 5-LOX was found to be overexpressed not only in pancreatic cancer cell lines b... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Inhibition of 5-lipoxygenase triggers apoptosis in pancreatic cancer cells. | DisGeNET | Detail |
| Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer c... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Inhibition of 5-lipoxygenase selectively triggers disruption of c-Myc signaling in prostate cancer c... | DisGeNET | Detail |
| Wedelolactone, a plant coumestan, was shown to act as anti-cancer agent for breast and prostate carc... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| These results suggest that the level of 5-LOX expression was increased in pancreatic cancer tissues ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Absence of ALOX5 gene prevents stress-induced memory deficits, synaptic dysfunction and tauopathy in... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The 5-lipoxygenase (5-LOX) pathway has been associated with a variety of inflammatory diseases inclu... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Absence of ALOX5 gene prevents stress-induced memory deficits, synaptic dysfunction and tauopathy in... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Inhibition of 5-LO by pharmacological or genetic approaches attenuates aneurysm formation and preven... | DisGeNET | Detail |
| Targeted interruption of the 5-LO pathway is a potential treatment strategy in AAA. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The eicosanoid genes ALOX5, ALOX5AP and LTA4H have been implicated in atherosclerosis. | DisGeNET | Detail |
| Our results provide the evidence that the administration of 5-LOX inhibitors is able to ameliorate T... | DisGeNET | Detail |
| The lipoxygenase isoform of 5-lipoxygenase (5-LOX) is reported to be overexpressed in human rheumato... | DisGeNET | Detail |
| The 5-lipoxygenase (5-LOX) pathway has been associated with a variety of inflammatory diseases inclu... | DisGeNET | Detail |
| The 5-lipoxygenase product 5-oxo-6,8,11,14-eicosatetraenoic acid (5-oxo-ETE) is the most powerful hu... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The eicosanoid genes ALOX5, ALOX5AP and LTA4H have been implicated in atherosclerosis. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| On treatment initiation, ALOX5 levels increased in all patients except those who were destined to pr... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs386592567 dbSNP
- Genome
- hg19
- Position
- chr10:45,869,624-45,941,567
- Variant Type
- snv
Genome browser